Interpretation and Presentation of Subgroup Analyses

Subgroup analyses are required for approval by all regulatory authorities but they are frequently poorly or interpreted incorrectly. For example, the differences between subgroup analyses for safety and efficacy data are often not properly understood and the most appropriate comparator group for different subgroups is not always apparent. This workshop uses a number of case studies to explore the most informative ways of analyzing subgroup analyses and the best ways to present and describe these results for maximum transparency and clinical application relevance.


back